Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Clinical trial NCT07221851 · RECRUITING

Trial details

NCT number: NCT07221851
Sponsor: Ascendis Pharma A/S
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Turner Syndrome Short Stature Homeobox Gene Mutation Idiopathic Short Stature Small for Gestational Age at Delivery

Start date: 2025-12-12
Primary completion: 2028-02-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.